Document is current
Any future updates will be listed below
-
Authors
Chang, Hsuan-Chia https://orcid.org/0000-0003-3478-5777
Tsai, Chung-Ying
Hsu, Cheng-Lung
Tai, Tzong-Shyuan https://orcid.org/0000-0003-0575-914X
Cheng, Mei-Ling https://orcid.org/0000-0003-2006-133X
Chuang, Yu-Ming
Tang, Hsiang-Yu https://orcid.org/0000-0002-2536-6370
Lin, Kun-Ju
Chen, Jia-Jin
Chang, Szu-Han
Ko, Yi-Ching
Chi, Yu-Wen https://orcid.org/0009-0009-8803-4435
Liu, Hsuan
Tan, Bertrand Chin-Ming
Shen, Chia-Rui
Yang, Chih-Wei
Ho, Ping-Chih https://orcid.org/0000-0003-3078-3774
Yang, Huang-Yu
- License Information
-
More Information
Article History
Received: 8 February 2024
Accepted: 12 February 2025
First Online: 5 March 2025
Competing interests
: P.-C.H. is a co-founder of Pilatus Biosciences and serves as scientific advisor board member for Pilatus Biosciences, Celyad Oncology and Elixiron Immunotherapeutics. The other authors declare no competing interests.
